The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 16, 2021

Filed:

Jun. 04, 2019
Applicant:

Suzhou Thinking Power Biotechnology Co., Ltd., Suzhou, CN;

Inventors:

Huashun Li, Suzhou, CN;

Baoyong Ren, Suzhou, CN;

Peng Liu, Suzhou, CN;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/765 (2006.01); A61P 9/00 (2006.01); A61K 9/08 (2006.01); A61K 38/17 (2006.01); C07K 14/47 (2006.01); C12N 15/62 (2006.01); C12N 15/85 (2006.01); A61K 38/00 (2006.01); A61P 11/16 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/765 (2013.01); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 38/1709 (2013.01); A61P 9/00 (2018.01); A61P 11/16 (2018.01); C07K 14/47 (2013.01); C07K 14/4702 (2013.01); C12N 15/62 (2013.01); C12N 15/85 (2013.01); A61K 38/00 (2013.01); C07K 2319/31 (2013.01);
Abstract

The present invention relates to the field of biomedical technology, in particular to a fusion protein Slit2D2(C386S)-HSA and use thereof in the treatment and/or prevention of fibrotic diseases. In the fusion protein, the amino acid residue is mutated on the basis of the Slit2D2 domain, which improves the stability of the fusion protein compared with the native protein. The above fusion protein is obtained by fusing Slit2D2(C386S) with HSA protein, which prolongs the metabolism time of the drug while improving the stability of the drug. The fusion protein provided by the present invention is more effective than the positive control drug in the prevention and treatment of fibrotic diseases, particularly pulmonary fibrosis, and shows good drug-forming properties.


Find Patent Forward Citations

Loading…